Tdf Gilead Lawsuit Update 2024

Tdf Gilead Lawsuit Update 2024. On june 11, 2024, gilead sciences agreed to a $40 million truvada settlement, resolving around 2,600 claims by patients who allege to have developed kidney and bone diseases while taking. The concurrent cases revolve around gilead’s older tenofovir disoproxil fumarate (tdf) based medicine, or viread, truvada and others, and its newer product made with.


Tdf Gilead Lawsuit Update 2024

Truvada was one of the first hiv drugs that was widely. Settlements of tdf lawsuits are likely to resolve the mass tort claims against gilead sciences, inc.

Tdf Gilead Lawsuit Update 2024 Images References :

Author